Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Mandelkern

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 1, 2017
Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine UsersScott J Moeller, Kyoji Okita, Chelsea L Robertson, et al.
Synapse (New York, N.Y.)|May 21, 2005
Differences in regional brain metabolism associated with marijuana abuse in methamphetamine abusersBradley Voytek, Steven M Berman, B Daniel Hassid, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 30, 2009
Effects of treatment for tobacco dependence on resting cerebral glucose metabolismMatthew R Costello, Mark A Mandelkern, Stephen Shoptaw, et al.
Biological Psychiatry|October 18, 2015
Deep Brain Stimulation of the Basolateral Amygdala for Treatment-Refractory Posttraumatic Stress DisorderJean-Philippe Langevin, Ralph J Koek, Holly N Schwartz, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 17, 2015
Striatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjectsChelsea L Robertson, Kenji Ishibashi, Mark A Mandelkern, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
Neuromodulation for Treatment-Refractory PTSDJean-Philippe Langevin, Ralph J Koek, Holly N Schwartz, et al.
Biological Psychiatry|January 7, 2004
Differences between smokers and nonsmokers in regional gray matter volumes and densitiesArthur L Brody, Mark A Mandelkern, Murray E Jarvik, et al.
JAMA Psychiatry|May 23, 2014
Brain nicotinic acetylcholine receptor availability and response to smoking cessation treatment: a randomized trialArthur L Brody, Alexey G Mukhin, Michael S Mamoun, et al.
Biological Psychiatry|July 31, 2009
Effect of a history of major depressive disorder on smoking-induced dopamine releaseArthur L Brody, Richard E Olmstead, Anna L Abrams, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 20, 2011
Dorsal striatal D2-like receptor availability covaries with sensitivity to positive reinforcement during discrimination learningStephanie M Groman, Buyean Lee, Edythe D London, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 1, 2017
Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine UsersScott J Moeller, Kyoji Okita, Chelsea L Robertson, et al.
Synapse (New York, N.Y.)|May 21, 2005
Differences in regional brain metabolism associated with marijuana abuse in methamphetamine abusersBradley Voytek, Steven M Berman, B Daniel Hassid, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 30, 2009
Effects of treatment for tobacco dependence on resting cerebral glucose metabolismMatthew R Costello, Mark A Mandelkern, Stephen Shoptaw, et al.
Biological Psychiatry|October 18, 2015
Deep Brain Stimulation of the Basolateral Amygdala for Treatment-Refractory Posttraumatic Stress DisorderJean-Philippe Langevin, Ralph J Koek, Holly N Schwartz, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 17, 2015
Striatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjectsChelsea L Robertson, Kenji Ishibashi, Mark A Mandelkern, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
Neuromodulation for Treatment-Refractory PTSDJean-Philippe Langevin, Ralph J Koek, Holly N Schwartz, et al.
Biological Psychiatry|January 7, 2004
Differences between smokers and nonsmokers in regional gray matter volumes and densitiesArthur L Brody, Mark A Mandelkern, Murray E Jarvik, et al.
JAMA Psychiatry|May 23, 2014
Brain nicotinic acetylcholine receptor availability and response to smoking cessation treatment: a randomized trialArthur L Brody, Alexey G Mukhin, Michael S Mamoun, et al.
Biological Psychiatry|July 31, 2009
Effect of a history of major depressive disorder on smoking-induced dopamine releaseArthur L Brody, Richard E Olmstead, Anna L Abrams, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 20, 2011
Dorsal striatal D2-like receptor availability covaries with sensitivity to positive reinforcement during discrimination learningStephanie M Groman, Buyean Lee, Edythe D London, et al.
Pageof 9